Cargando…

A case of ultrashort‐acting beta‐blocker landiolol hydrochloride for takotsubo syndrome with left ventricular outflow tract obstruction

Takotsubo syndrome (TTS) has been known to have a favorable prognosis. Beta‐blockers are reported to be effective for TTS patients with cardiogenic heart failure due to left ventricular outflow tract (LVOT) obstruction. However, there is no report on ultrashort‐acting beta‐blockers being used for tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takama, Takuro, Fukue, Mitsunori, Sato, Hiroyuki, Taniuchi, Masato
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399582/ https://www.ncbi.nlm.nih.gov/pubmed/30873307 http://dx.doi.org/10.1002/jgf2.223

Ejemplares similares

Treatment of pulmonary thromboembolism with edoxaban in a cancer patient with borderline fulfillment of the dose reduction criteria
por: Takama, Takuro, et al.
Publicado: (2019)

Beta-Blocker Landiolol Hydrochloride in Preventing Atrial Fibrillation Following Cardiothoracic Surgery: A Systematic Review and Meta-Analysis
por: Hao, Jianqi, et al.
Publicado: (2021)

Perioperative Administration of an Intravenous Beta-Blocker Landiolol Hydrochloride in Patients with Lung Cancer: A Japanese Retrospective Exploratory Clinical Study
por: Sakamoto, Atsuhiro, et al.
Publicado: (2019)

Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension
por: Schroeder, Lukas, et al.
Publicado: (2022)

Dose-Finding Study of Landiolol Hydrochloride: A Short-Acting β(1)-Blocker for Controlling Heart Rate During Coronary Computed-Tomography Angiography in Japan
por: Hirano, Masaharu, et al.
Publicado: (2013)

Safety and Efficacy of Landiolol Hydrochloride in Children with Tachyarrhythmia of Various Etiologies
por: Ashida, Atsuko, et al.
Publicado: (2021)

Practical applicability of landiolol, an ultra-short-acting β1-selective blocker, for rapid atrial and ventricular tachyarrhythmias with left ventricular dysfunction
por: Wada, Yuko, et al.
Publicado: (2016)

The Effectiveness and Safety of Landiolol Hydrochloride, an Ultra-Short-Acting β(1)-Blocker, in Postoperative Patients with Supraventricular Tachyarrhythmias: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
por: Taenaka, Nobuyuki, et al.
Publicado: (2013)

Effect of Landiolol Hydrochloride on Hemodynamics in a Histamine-Induced Shock Model
por: Hirano, Masaharu, et al.
Publicado: (2021)

A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β(1)-blocker, landiolol hydrochloride, in patients with suspected ischemic cardiac disease
por: Jinzaki, Masahiro, et al.
Publicado: (2013)

Manifestation of Latent Left Ventricular Outflow Tract Obstruction in the Acute Phase of Takotsubo Cardiomyopathy
por: Ozaki, Kazuyuki, et al.
Publicado: (2016)

Dynamic left ventricular outflow tract obstruction in Takotsubo cardiomyopathy resulting in cardiogenic shock
por: Conradi, Paulina M, et al.
Publicado: (2021)

Landiolol, an ultra-short acting beta-1 blocker, for preventing postoperative lung cancer recurrence: study protocol for a phase III, multicenter randomized trial with two parallel groups of patients
por: Yamamoto, Haruko, et al.
Publicado: (2019)

Dose-dependent scavenging activity of the ultra-short-acting β1-blocker landiolol against specific free radicals
por: Matsumoto, Shigekiyo, et al.
Publicado: (2022)

Impella in Takotsubo syndrome complicated by left ventricular outflow tract obstruction and severe mitral regurgitation
por: Attisano, Tiziana, et al.
Publicado: (2020)

Impella Use in Cardiogenic Shock Due to Takotsubo Cardiomyopathy With Left Ventricular Outflow Tract Obstruction
por: Mohammedzein, Assad, et al.
Publicado: (2019)

Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in patients with peripheral arterial disease
por: Kunisawa, Takayuki, et al.
Publicado: (2015)

Landiolol hydrochloride for prevention of atrial fibrillation during esophagectomy: a randomized controlled trial
por: Aoki, Yoshitaka, et al.
Publicado: (2020)

Dose-Dependent Effect of Landiolol, a New Ultra-Short-Acting β(1)-Blocker, on Supraventricular Tachyarrhythmias in Postoperative Patients
por: Taenaka, Nobuyuki, et al.
Publicado: (2013)

Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature
por: Matsuishi, Yujiro, et al.
Publicado: (2020)

The Use of Beta Blockers in Takotsubo Syndrome as Compared to Acute Coronary Syndrome
por: Kummer, Marvin, et al.
Publicado: (2020)

Beta Blockers as Salvage Treatment in Refractory Septic Shock Complicated With Dynamic Left Ventricular Outflow Tract Obstruction: A Rare Case Presentation
por: Pablo, Catalá-Ruiz, et al.
Publicado: (2021)

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Short-Acting β(1)-Adrenergic Receptor Blocker Landiolol Hydrochloride for Coronary Computed Tomography Angiography in Japanese Patients with Suspected Ischemic Cardiac Disease
por: Hirano, Masaharu, et al.
Publicado: (2013)

Fibroelastomas of the left ventricular outflow tract
por: Kesavan, Sujatha, et al.
Publicado: (2011)

Left Ventricular Outflow Tract Tachycardias
por: Francis, Johnson
Publicado: (2013)

Development and Morphology of the Ventricular Outflow Tracts
por: Anderson, Robert H., et al.
Publicado: (2016)

Safety of Landiolol Hydrochloride as a Premedication for Producing an Appropriate Heart Rate for Multidetector-Row Computed Tomography Coronary Angiography
por: Koyoshi, Rie, et al.
Publicado: (2018)

A case report of cardiogenic shock from takotsubo cardiomyopathy with left ventricular outflow tract obstruction: fundamental lessons in cardiac pathophysiology
por: Bui, Quan M, et al.
Publicado: (2021)

Successful Treatment of Cardiogenic Shock Due to Takotsubo Cardiomyopathy With Left Ventricular Outflow Tract Obstruction and Acute Mitral Regurgitation by Impella CP
por: Benak, Ales, et al.
Publicado: (2022)

Prevalence, associated factors and management implications of left ventricular outflow tract obstruction in takotsubo cardiomyopathy: a two-year, two-center experience
por: De Backer, Ole, et al.
Publicado: (2014)

Left ventricular outflow track obstruction and mitral valve regurgitation in a patient with takotsubo cardiomyopathy
por: Wu, Yin, et al.
Publicado: (2015)

Characteristic interactivity of landiolol, an ultra-short-acting highly selective β(1)-blocker, with biomimetic membranes: Comparisons with β(1)-selective esmolol and non-selective propranolol and alprenolol
por: Tsuchiya, Hironori, et al.
Publicado: (2013)

Safety and effective use of landiolol in the ICU
por: Hifumi, Toru, et al.
Publicado: (2014)

Dynamic left ventricular outflow tract gradient resulting from Takotsubo cardiomyopathy ameliorated by intra-aortic balloon pump counterpulsation: a case report
por: O’Brien, Jim, et al.
Publicado: (2021)

Anti-inflammatoryactivity of calciumchannel blocker lercanidipine hydrochloride
por: Vasigar, Prathap, et al.
Publicado: (2013)

Recurrent takotsubo syndrome with worsening of left ventricular outflow obstruction during haemodialysis: a case report
por: Takada, Takuma, et al.
Publicado: (2020)

Huge Hydatid Cyst of the Right Ventricular Outflow Tract
por: Shakerian, Behnam, et al.
Publicado: (2021)

Metastasizing Leiomyoma Obstructing the Right Ventricular Outflow Tract
por: Abalo, Miguel Ruben, et al.
Publicado: (2020)

An Unusual Case of Left Ventricular Outflow Tract Pseudoaneurysm
por: Assi, Abdul Elah H., et al.
Publicado: (2022)

Study of hemodynamics in patients treated with landiolol in the ICU
por: Imabayashi, T, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_jl3ef18dqk2n8hod28g92cpq0n